AXSM Market Cap & Key Metrics
Axsome Therapeutics, Inc.
$161.79
-$0.43(-0.27%)
40
Overall
40
Value
9
Tech
71
Quality
Market Cap
$8.50B
Volume
802.58K
52W Range
$119.20 - $260.19
Target Price
$279.55
AXSM market cap is $8.50B. This page lists Axsome Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
AXSM Key Metrics
- Market cap
- $8.50B
- EPS estimate, current year
- $-2.92
- EPS growth, 3-year
- +7.17%
- Value score
- 40
- Quality score
- 71
- Technical score
- 9
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $638.50M | $385.69M | $270.60M | $50.04M | - |
| EBITDA | -$173.34M | -$276.53M | -$228.87M | -$181.29M | -$124.63M |
| EPS | $-3.68 | $-5.99 | $-5.27 | $-4.60 | $-3.47 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AXSM | $161.79 | -0.3% | 802.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Axsome Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW